Dexcom Inc
- Stock
- Ticker DXCM
- ISIN US2521311074
- Nasdaq
Performance, volatility and drawdowns of Dexcom Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $43,356. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −66.3% in 11/2025, measured from the peak in 11/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 1,114 | 1,036 | 1,157 | 1,209 | 1,260 | 1,192 | 1,308 | 1,345 |
| Gross profit | 656 | 589 | 689 | 731 | 793 | 750 | 830 | 864 |
| Operating income | 189 | 134 | 213 | 243 | 323 | 255 | 318 | 327 |
| EBITDA | 247 | 194 | 276 | 306 | 388 | 322 | 387 | 402 |
| Net income | 152 | 105 | 180 | 284 | 267 | 200 | 249 | 275 |
| Earnings per share | 0.38 | 0.27 | 0.45 | 0.70 | 0.67 | 0.51 | 0.64 | 0.72 |
| Balance sheet | ||||||||
| Total assets | 6,485 | 6,752 | 7,327 | 7,500 | 6,340 | 6,633 | 6,455 | 6,239 |
| Liabilities | 4,382 | 4,485 | 4,754 | 4,774 | 3,594 | 3,676 | 3,834 | 3,703 |
| Equity | 2,103 | 2,267 | 2,573 | 2,726 | 2,746 | 2,957 | 2,621 | 2,535 |
| Cash | 606 | 905 | 1,159 | 1,836 | 918 | 1,118 | 1,105 | 961 |
| Cash flow | ||||||||
| Operating cash flow | 301 | 184 | 303 | 660 | 294 | 526 | 269 | 326 |
| Capital expenditure | -125 | -87 | -94 | -81 | -102 | -77 | -85 | -53 |
| Free cash flow | 177 | 97 | 209 | 579 | 192 | 449 | 185 | 273 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2018 at +108.7%, weakest 2024 at −37.3%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 29 Oct 2026 | $0.72 |
| 30 Jul 2026 | $0.64 |
| 30 Apr 2026 | $0.51 |
| 12 Feb 2026 | $0.67 |
| 30 Oct 2025 | $0.70 |
| 30 Jul 2025 | $0.45 |
| 1 May 2025 | $0.27 |
| 18 Feb 2025 | $0.38 |
| 24 Oct 2024 | $0.34 |
| 25 Jul 2024 | $0.35 |
| 25 Apr 2024 | $0.36 |
| 8 Feb 2024 | $0.61 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €27bn
- Market cap in trading currency
- $29.6bn
- Enterprise value
- $28.6bn
- P/E
- 31.2
- P/S
- 5.80
- P/B
- 11.67
- EV/Sales
- 5.61
- EV/EBITDA
- 19.1
- Earnings yield
- 3.2%
- FCF yield
- 3.7%
Results (last four quarters)
- Revenue
- $5.10bn
- Gross profit
- $3.24bn
- EBITDA
- $1.50bn
- Net income
- $991m
- Earnings per share
- $2.54
- Revenue per share
- $13.69
- Revenue growth
- +11.2%
- Earnings growth
- −3.1%
Profitability
- Gross margin
- 63.4%
- Operating margin
- 24.0%
- Net margin
- 19.4%
- Return on equity
- 37.7%
- Return on assets
- 15.9%
Balance sheet and cash flow
- Cash
- $961m
- Cash per share
- $2.58
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 1.74
- Book value per share
- $6.80
- Operating cash flow
- $1.41bn
- Free cash flow
- $1.10bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 373m
- Volume
- 4.41m
- Avg. volume 3 months
- 4.23m
- Relative volume
- 1.1
Price and technicals
- Price
- $79.32
- 1 day
- −1.1%
- 52-week high
- $92.34
- 52-week low
- $57.56
- Distance to 52-week high
- −14.1%
- Distance to 52-week low
- +37.8%
- Distance to 50-day line
- −5.5%
- Distance to 200-day line
- +5.3%
- RSI (14)
- 43
- Volatility 1M
- 44.1%
Performance
- 1 week
- −4.8%
- 1 month
- +1.3%
- 3 months
- −12.9%
- 6 months
- +10.0%
- YTD
- +19.5%
- 1 year
- +32.8%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has DXCM performed since 11/2016?
$10,000 grew to $43,356 by 20 Nov 2026, which is +15.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is DXCM?
Volatility was 51.5% per year, measured on monthly returns. The largest decline from a peak was −66.3%, with the low in 11/2025.
How does DXCM compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, DXCM returned +15.8% at 51.5%. The correlation of monthly returns was 0.29; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.